Sign in

CIK 0001422143

  • Non-accelerated filer
  • Smaller reporting company

Kura Oncology, Inc.

Sign in to watch
Ticker
KURA
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
611547851
Phone
+1 858-500-8800
Business address
4930 DIRECTORS PLACE, SUITE 500, SAN DIEGO, CA, 92121
Former names
ZETA ACQUISITION CORP III
Open-market buys, last 90 days
$4,248,530
in 3 filings
Open-market sales, last 90 days
$1,310,361
in 7 filings, $252K under 10b5-1 plans

Net +$2,938,169. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 38 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2022-01-26 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +261,000 261,000
2022-01-26 WILSON TROY EDWARD President and CEO Grant or award · Option to purchase common stock +495,000 495,000
2021-10-18 Bair Teresa Brophy Chief Legal Officer Grant or award · Option to purchase common stock +192,000 192,000
2021-07-28 Collins Helen Louise Director Grant or award · Option to purchase common stock +46,000 46,000
2021-07-28 Collins Helen Louise Director Grant or award · Option to purchase common stock +19,166 19,166
2021-06-22 SCHAFER CAROL Director Grant or award · Option to purchase common stock +23,000 23,000
2021-06-22 Parks Diane L. Director Grant or award · Option to purchase common stock +23,000 23,000
2021-06-22 Szela Mary T Director Grant or award · Option to purchase common stock +23,000 23,000
2021-06-22 Stein Steven H Director Grant or award · Option to purchase common stock +23,000 23,000
2021-06-22 Malley Thomas Director Grant or award · Option to purchase common stock +23,000 23,000
2021-06-22 Hasnain Faheem Director Grant or award · Option to purchase common stock +23,000 23,000
2021-06-22 HOFFMAN ROBERT Director Grant or award · Option to purchase common stock +23,000 23,000
2021-06-03 SCHAFER CAROL Director Grant or award · Option to purchase common stock +46,000 46,000
2021-03-15 FORD KATHLEEN Chief Operating Officer Exercise or conversion +6,250 $19.43 $121K 6,250
2021-03-15 FORD KATHLEEN Chief Operating Officer Sale −6,250 $29.43 $184K 0
2021-03-15 FORD KATHLEEN Chief Operating Officer Exercise or conversion · Option to purchase common stock −6,250 215,625
2021-01-26 BASTA JAMES Chief Legal Officer Grant or award · Option to purchase common stock +125,000 125,000
2021-01-26 FLOWERS KIRSTEN Chief Commercial Officer Grant or award · Option to purchase common stock +125,000 125,000
2021-01-26 FORD KATHLEEN Chief Operating Officer Grant or award · Option to purchase common stock +140,000 140,000
2021-01-26 DALE STEPHEN Chief Medical Officer Grant or award · Option to purchase common stock +100,000 100,000

Page 12 of 19 · 366 trades